Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Patient income level and cancer clinical trial participation.

Unger JM, Hershman DL, Albain KS, Moinpour CM, Petersen JA, Burg K, Crowley JJ.

J Clin Oncol. 2013 Feb 10;31(5):536-42. doi: 10.1200/JCO.2012.45.4553. Epub 2013 Jan 7.

2.

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL.

J Natl Cancer Inst. 2014 Sep 13;106(10). pii: dju216. doi: 10.1093/jnci/dju216. Print 2014 Oct.

3.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

4.

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.

Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M.

Cancer. 2003 Mar 15;97(6):1499-506.

5.

Participation of older patients with prostate cancer in Medicare eligible trials.

Craig BM, Gilbert SM, Herndon JB, Vogel B, Quinn GP.

J Urol. 2010 Sep;184(3):901-6. doi: 10.1016/j.juro.2010.04.076.

6.

Tumor board participation among physicians caring for patients with lung or colorectal cancer.

Kehl KL, Landrum MB, Kahn KL, Gray SW, Chen AB, Keating NL.

J Oncol Pract. 2015 May;11(3):e267-78. doi: 10.1200/JOP.2015.003673. Epub 2015 Apr 28.

7.

Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

Wong YN, Schluchter MD, Albrecht TL, Benson AB 3rd, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ.

J Clin Oncol. 2016 Feb 10;34(5):479-87. doi: 10.1200/JCO.2015.63.2463. Epub 2015 Dec 23.

8.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

9.

Cancer trial enrollment after state-mandated reimbursement.

Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM.

J Natl Cancer Inst. 2004 Jul 21;96(14):1063-9.

PMID:
15265967
10.

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, Lara PN Jr, Williams PA, Hutchins LF, Gotay CC, Albain KS.

Oncologist. 2012;17(9):1180-90. Epub 2012 Jun 20.

11.

A population-based assessment of specialty physician involvement in cancer clinical trials.

Klabunde CN, Keating NL, Potosky AL, Ambs A, He Y, Hornbrook MC, Ganz PA.

J Natl Cancer Inst. 2011 Mar 2;103(5):384-97. doi: 10.1093/jnci/djq549. Epub 2011 Feb 11.

12.

Barriers to cancer clinical trial participation among Native elders.

LaVallie DL, Wolf FM, Jacobsen C, Buchwald D.

Ethn Dis. 2008 Spring;18(2):210-7.

PMID:
18507276
13.

Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer.

Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS.

Med Care. 2004 Feb;42(2):116-22.

PMID:
14734948
14.

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.

Melisko ME, Hassin F, Metzroth L, Moore DH, Brown B, Patel K, Rugo HS, Tripathy D.

Clin Breast Cancer. 2005 Apr;6(1):45-54.

PMID:
15899072
15.

Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors.

Baquet CR, Commiskey P, Daniel Mullins C, Mishra SI.

Cancer Detect Prev. 2006;30(1):24-33. Epub 2006 Feb 21.

16.
17.

Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study.

Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL.

JAMA Oncol. 2016 Jan;2(1):137-9. doi: 10.1001/jamaoncol.2015.3924. No abstract available.

18.

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Manne S, Kashy D, Albrecht T, Wong YN, Lederman Flamm A, Benson AB 3rd, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ.

Eur J Cancer Care (Engl). 2015;24(1):28-38. doi: 10.1111/ecc.12180. Epub 2014 Jan 28.

19.

Altruism among participants in cancer clinical trials.

Truong TH, Weeks JC, Cook EF, Joffe S.

Clin Trials. 2011 Oct;8(5):616-23. doi: 10.1177/1740774511414444. Epub 2011 Aug 3.

PMID:
21813584
20.

An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.

Markman M, Petersen J, Montgomery R.

J Cancer Res Clin Oncol. 2008 Jan;134(1):115-8. Epub 2007 Jun 28.

PMID:
17598129

Supplemental Content

Support Center